A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/11/2004	CA2523508A1 Galectin 9-inducing factors
11/11/2004	CA2523402A1 Group 1 mite polypeptide variants
11/11/2004	CA2521158A1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
11/11/2004	CA2518947A1 Antiallergic composition
11/10/2004	EP1475443A2 Vectors having enhanced expression and methods of making and uses thereof
11/10/2004	EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
11/10/2004	EP1475091A1 Mycophenolate mofetil - high dose oral suspensions
11/10/2004	EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases
11/10/2004	EP1474451A2 De-immunized (poly)peptide constructs
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation
11/10/2004	EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004	EP1045700B1 Oral delivery of nucleic acid vaccines by particulate complexes
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545417A Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine
11/10/2004	CN1544630A Method for preparing recombinant duck interleukin-2 protein and its application
11/10/2004	CN1544508A Poly acid anhydride for release-controlled medicine carrier and method for producing the same
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544040A Medicine for increasing immunocompetence of children and its preparing process
11/10/2004	CN1544037A Health care medicine capable of strengthening heart and kidney function and immunologic function
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/10/2004	CN1174690C Capsule containing wolfberry fruit extract and its preparing process
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815449 An immunosuppressants for treating autoimmune diseases, antiallergic agents, antitumor agents
11/09/2004	US6815429 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/09/2004	US6814981 Ganglioside immunostimulating complexes and uses thereof
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094381A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	WO2004093909A1 Methods to regulate biofilm formation
11/04/2004	WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
11/04/2004	WO2004093903A2 Methods and compositions for immunomodulation using cd1 antigens
11/04/2004	WO2004093899A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	WO2004093898A2 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	WO2004093897A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	WO2004093894A2 Use of b7-h3 as an immunoregulatory agent
11/04/2004	WO2004093882A1 Remedies for diseases to be applied to eye
11/04/2004	WO2004093863A1 A composition comprising an edible acid or its acidic salt and the use thereof
11/04/2004	WO2004093862A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	WO2004083372A3 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004062653A3 The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003082867A8 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003015716A3 Immunoglobulin e vaccines and methods of use thereof
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220508 Species binding device and method of making
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220388 Novel heterodimeric fusion proteins
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220227 Remedies for allergic eye diseases

1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 1172